Concord Biotech, Natco Pharma among 10 smallcap stocks that crashed up to 41% this week – Worst Performers

Concord Biotech, Natco Pharma among 10 smallcap stocks that crashed up to 41% this week – Worst Performers

Concord Biotech saw a weekly decline of 27.71%, with the stock closing at Rs 1693.20 on the BSE at the end of the week. (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times) Source link

These 5 BSE smallcap stocks see price and volume jump in last 3 days – Investor Buzz

These 5 BSE smallcap stocks see price and volume jump in last 3 days – Investor Buzz

Indian Railway Finance Corporation Share Price 161.43 04:01 PM | 20 Sep 2024 6.19(3.99%) Suzlon Energy Share Price 83.45 03:59 PM | 20 Sep 2024 2.49(3.07%) Indian Renewable Energy Development Agency Share Price 232.37 03:59 PM | 20 Sep 2024 2.37(1.03%) Tata Motors Share Price 970.85 03:59 PM | 20 Sep 2024 3.86(0.4%) YES Bank … Read more

UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals

UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals

UBS was on a selling spree on Friday as the Zurich-based bank and financial services company sold its holding in four stocks through UBS Principal Capital Asia Limited via block deals. The stocks included Concord Biotech, Five Star Business Finance, IIFL Securities and Marksans Pharma and the total share sale aggregated to Rs 480 crore. … Read more

September likely to witness a flood of locked-in shares

September likely to witness a flood of locked-in shares

Mumbai: Locked-in shares of at least 10 companies could find their way into the open market in September as the deadline for investors to compulsorily hold these shares bought through pre-Initial Public Offer (IPO) placements ends. Computer Age Management (CAMS), Concord Biotech, SBFC Finance, Happiest Minds, Route Mobile, and Chemcon Speciality, are among the companies … Read more

Another Jhunjhunwala long bet blooms with Concord Biotech offer

Another Jhunjhunwala long bet blooms with Concord Biotech offer

Mumbai: Rakesh Jhunjunwala-backed Concord Biotech launched its IPO Friday, joining the ranks of the late billionaire’s other private investment portfolio companies such as Star Health, Metro Brands and Nazara Technologies that have gone public in the past couple of years. The ace investor often called India’s Warren Buffet, first invested in Concord in 2004 and … Read more

SBFC Finance vs Concord Biotech: Which IPO should you pick?

SBFC Finance vs Concord Biotech: Which IPO should you pick?

The Street is buzzing with IPOs with two of them, SBFC Finance and Concord Biotech, currently open for subscription. While both the issues have received thumbs-up from analysts, they clearly prefer SBFC Finance over the other if investors had to pick one. SBFC Finance IPO, which closes on Monday, is reasonably priced, offering room to … Read more

TVS Supply Chain Solutions, Srivari Spices IPOs to open next week. Check details

TVS Supply Chain Solutions, Srivari Spices IPOs to open next week. Check details

Action in the primary market is expected to remain high next week as well. The mainboard initial public offering (IPO) of TVS Supply Chain Solutions will open on Thursday, July 10. In the SME space, Srivari Spices and Foods will launch its public issue on Monday, August 7. Investors will also have the opportunity to … Read more